These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18660792)

  • 41. Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy.
    Donaldson AR; McCarthy C; Goraya S; Pederson HJ; Sturgis CD; Grobmyer SR; Calhoun BC
    Cancer; 2018 Feb; 124(3):459-465. PubMed ID: 29023647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
    Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
    Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ.
    Crisi GM; Ricci A
    Am J Surg Pathol; 2005 Dec; 29(12):1684-5; author reply 1685-6. PubMed ID: 16327444
    [No Abstract]   [Full Text] [Related]  

  • 44. Lobular Neoplasia.
    Lunt L; Coogan A; Perez CB
    Surg Clin North Am; 2022 Dec; 102(6):947-963. PubMed ID: 36335930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphological parameters of lobular in situ neoplasia in stereotactic 11-gauge vacuum-assisted needle core biopsy do not predict the presence of malignancy on subsequent surgical excision.
    Bianchi S; Bendinelli B; Castellano I; Piubello Q; Renne G; Cattani MG; Stefano DD; Carrillo G; Laurino L; Bersiga A; Giardina C; Dante S; Loreto CD; Quero C; Antonacci CM; Palli D;
    Histopathology; 2013 Jul; 63(1):83-95. PubMed ID: 23692123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen.
    Yeh IT; Dimitrov D; Otto P; Miller AR; Kahlenberg MS; Cruz A
    Arch Pathol Lab Med; 2003 Jan; 127(1):49-54. PubMed ID: 12521366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
    Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
    AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting.
    Ely KA; Carter BA; Jensen RA; Simpson JF; Page DL
    Am J Surg Pathol; 2001 Aug; 25(8):1017-21. PubMed ID: 11474285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation.
    Georgian-Smith D; Lawton TJ
    AJR Am J Roentgenol; 2001 May; 176(5):1255-9. PubMed ID: 11312190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.
    Mooney KL; Bassett LW; Apple SK
    Mod Pathol; 2016 Dec; 29(12):1471-1484. PubMed ID: 27538687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
    Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
    AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of in situ lobular neoplasia detected on needle core biopsy of breast.
    Purdie CA; McLean D; Stormonth E; Macaskill EJ; McCullough JB; Edwards SL; Brown DC; Jordan LB
    J Clin Pathol; 2010 Nov; 63(11):987-93. PubMed ID: 20972243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
    Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
    Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
    Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
    Calle C; Kuba MG; Brogi E
    Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of four-quadrant random sections in mastectomy specimens.
    Gupta D; Nath M; Layfield LJ
    Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
    Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
    Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.
    Pride RM; Jimenez RE; Hoskin TL; Degnim AC; Hieken TJ
    Surgery; 2021 Mar; 169(3):644-648. PubMed ID: 32861439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.